What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Cancer
Kris Thielemans focuses on Antigen, Immunology, Antigen presentation, Dendritic cell and Cytotoxic T cell.
His Antigen research is multidisciplinary, incorporating elements of Molecular biology, Virology, Immune system and Cancer immunotherapy.
Kris Thielemans interconnects Cell and Interleukin 12 in the investigation of issues within Immunology.
His Antigen presentation research incorporates elements of Priming, Human leukocyte antigen, Follicular dendritic cells, Major histocompatibility complex and Tumor antigen.
His research integrates issues of CD40, T cell, Antigen-presenting cell, Monocyte and Cell biology in his study of Dendritic cell.
His Cytotoxic T cell study incorporates themes from Immunoglobulin light chain, CD3, Melanoma and Vaccination.
His most cited work include:
- CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. (953 citations)
- Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia (699 citations)
- Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation (474 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Antigen, Immunotherapy, Cancer research and Immune system are his primary areas of study.
His study brings together the fields of Cytotoxic T cell and Immunology.
The various areas that he examines in his Antigen study include Molecular biology, Tumor antigen and Cancer immunotherapy.
Within one scientific family, Kris Thielemans focuses on topics pertaining to Vaccination under Immunotherapy, and may sometimes address concerns connected to Oncology.
Kris Thielemans has researched Immune system in several fields, including Ex vivo and In vivo.
His research in Dendritic cell intersects with topics in Interleukin, Antigen-presenting cell, Monocyte and Cell biology.
He most often published in these fields:
- Immunology (49.13%)
- Antigen (34.78%)
- Immunotherapy (26.96%)
What were the highlights of his more recent work (between 2012-2021)?
- Immunology (49.13%)
- Immunotherapy (26.96%)
- Cancer research (24.35%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Immunology, Immunotherapy, Cancer research, Immune system and Antigen.
His work on T cell is typically connected to Myeloid-derived Suppressor Cell as part of general Immunology study, connecting several disciplines of science.
His Immunotherapy study integrates concerns from other disciplines, such as Cytotoxic T cell, Dendritic cell and Transfection.
His work is dedicated to discovering how Dendritic cell, Cell biology are connected with Antigen presentation, IL-2 receptor and Electroporation and other disciplines.
His Immune system research includes elements of Autologous stem-cell transplantation, Multiple myeloma and Vaccination.
As a member of one scientific family, Kris Thielemans mostly works in the field of Antigen, focusing on Virus and, on occasion, DNA vaccination.
Between 2012 and 2021, his most popular works were:
- Lung-resident eosinophils represent a distinct regulatory eosinophil subset (182 citations)
- Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas (148 citations)
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma (138 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Cancer
The scientist’s investigation covers issues in Immunology, Immune system, Immunotherapy, Antigen and T cell.
Kris Thielemans works in the field of Immunology, namely Cancer immunotherapy.
His study looks at the intersection of Immune system and topics like In vivo with CD3 and Angiogenesis.
His study in Immunotherapy is interdisciplinary in nature, drawing from both Dendritic cell and Transfection.
Many of his studies on Antigen apply to Cancer research as well.
His T cell research integrates issues from Cytotoxic T cell, CD40 and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
